Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist Watchlist | Portfolio Portfolio | Dashboard Dashboard
Hi,
Site News
Contact
Market:
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Oncocyte Corp (OCX)

Oncocyte Corp (OCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville GlobeNewswire - Tue Jun 17, 2025

OCX : 3.20 (+17.22%)
IMDX : 4.13 (-3.73%)
Medicare Boosts Reimbursement for Oncocyte’s Flagship Technology GlobeNewswire - Mon May 19, 2025

New price of $2,753 for the GraftAssureCore™ assay increases total addressable market size and margin opportunityBrings pricing in line with existing...

OCX : 3.20 (+17.22%)
Medicare Boosts Reimbursement for Oncocyte’s Flagship Technology GlobeNewswire - Mon May 19, 2025

OCX : 3.20 (+17.22%)
OncoCyte: Q1 Earnings Snapshot AP - Mon May 12, 2025

OncoCyte: Q1 Earnings Snapshot

OCX : 3.20 (+17.22%)
Oncocyte Reports Q1 2025 Results and Business Progress GlobeNewswire - Mon May 12, 2025

Q1 2025 pharma services revenue of $2.1 million, at 62% gross marginThree of the top 10 U.S. transplant centers expected to participate in clinical...

OCX : 3.20 (+17.22%)
Oncocyte Reports Q1 2025 Results and Business Progress GlobeNewswire - Mon May 12, 2025

OCX : 3.20 (+17.22%)
Oncocyte to Release First Quarter 2025 Results on May 12, 2025 GlobeNewswire - Wed May 7, 2025

OCX : 3.20 (+17.22%)
Oncocyte to Release First Quarter 2025 Results on May 12, 2025 GlobeNewswire - Wed May 7, 2025

Oncocyte to Release First Quarter 2025 Results on May 12, 2025...

OCX : 3.20 (+17.22%)
Best Momentum Stocks to Buy for May 6th
Best Momentum Stocks to Buy for May 6th Zacks Investment Research - Tue May 6, 2025

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 6th:MAIA Biotechnology, Inc. MAIA: This immuno-oncology company has a Zacks Rank #1 and witnessed...

OCX : 3.20 (+17.22%)
BYRN : 3.59 (-0.42%)
MAIA : 1.3300 (-3.62%)
Oncocyte Provides Positive Update on Clinical Trial Progress GlobeNewswire - Wed Apr 30, 2025

OCX : 3.20 (+17.22%)

Barchart Exclusives

Strategy Stock Surges as Bitcoin Briefly Tops $80K Barchart - 14 minutes ago
MSTR stock jumped as Bitcoin topped $80,000 this week, fueled by Treasury bond buybacks, a short squeeze, and returning institutional demand. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.